Data mining the human gut microbiota for therapeutic targets

Briefings in Bioinformatics

Volumn 13, Issue 6, 2012, Pages 751-768

  Collison, Matthew ^a   Hirt, Robert P ^a   Wipat, Anil ^a   Nakjang, Sirintra ^a   Sanseau, Philippe ^b   Brown, James R ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Bioinformatics; Computational biology; Drug discovery; Microbiome

Indexed keywords

PROBIOTIC AGENT; RNA 16S;

ARTICLE; DATA MINING; GASTROINTESTINAL TRACT; GENETICS; HUMAN; METAGENOME; MICROBIOLOGY;

DATA MINING; GASTROINTESTINAL TRACT; HUMANS; METAGENOME; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 84869234211     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbs002     Document Type: Article

References (126)

1. Kiley JP. Advancing respiratory research. Chest 2011;140: 497-501.
2. Danielsson D, Teigen PK, Moi H. The genital econiche: focus on microbiota and bacterial vaginosis. Ann NYAcad Sci 2011;1230:48-8.
3. Sekirov I, Russell SL, Antunes LCM, et al. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
4. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011;9:244-53.
5. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124:837-48.
6. Savage DC. Microbial ecology of the gastrointestinal tract. Ann RevMicrobiol 1977;31:107-33.
7. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
8. Nelson KE, Weinstock GM, Highlander SK, et al. A catalog of reference genomes from the human microbiome. Science 2010;328:994-9.
9. Ehrlich SD. The Metahit Consortium. MetaHIT: The European Union Project on Metagenomics of the Human Intestinal Tract. In: Nelson KE, (ed). Metagenomics of theHuman body. Springer, 2011, 307-16.
10. Brown JR, Magid-Slav M, Sanseau P, et al. Computational biology approaches for selecting host-pathogen drug targets. Drug DiscovToday 2011;16:229-36.
11. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. ProcNatl Acad SciUSA 1998;95:6578-83.
12. Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009;106:3698-703.
13. Sekirov I, Russell SL, Antunes LCM, et al. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
14. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBORep 2006;7:688-93.
15. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat RevMicro 2011;9:279-90.
16. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010;5:e10667.
17. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-8.
18. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457: 480-4.
19. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80.
20. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. ProcNatlAcad Sci USA 2010;107:14691-6.
21. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. ProcNatl Acad SciUSA 2010;107:11971-5.
22. Hehemann J-H, Correc G, Barbeyron T, et al. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-12.
23. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010;10:159-69.
24. Wells JM, Rossi O, Meijerink M, et al. Epithelial crosstalk at the microbiota-mucosal interface. ProcNatlAcad SciUSA 2011;108:4607-14.
25. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729-37.
26. Willing BP, Gill N, Finlay BB. The role of the immune system in regulating the microbiota. Gut Microbes 2010;1: 213-23.
27. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
28. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729-37.
29. Boorom KF. Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel disease (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med Hypotheses 2007; 69:652-9.
30. Elliott DE, Weinstock JV. Helminthic therapy: using worms to treat immune-mediated disease. Adv Exp Med Biol 2009;666:157-66.
31. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009;15:128-33.
32. Burcelin R, Serino M, Chabo C, et al. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetologica 2011.
33. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-3.
34. Dumas M-E, Barton RH, Toye A, etal. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006;103:12511-6.
35. Saulnier DM, Riehle K, Mistretta T-A, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011;141: 1782-91.
36. Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:179-84.
37. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.
38. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. PharmacolTher 2011;130:202-12.
39. Thuny F, Richet H, Casalta J-P, et al. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 2010;5:e9074.
40. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133-42.
41. Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60: 49-54.
42. Hartman AL, Lough DM, Barupal DK, et al. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci USA 2009;106: 17187-92.
43. Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PLoS One 2011;6: e20447.
44. Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474:327-36.
45. McLoughlin RM, Mills KHG. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 2011;127: 1097-107. quiz 1108-9.
46. Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 2011;33: 574-81.
47. Hopkins AL, Groom CR. The druggable genome. NatRev DrugDiscov 2002;1:727-30.
48. Plewczynski D, Rychlewski L. Meta-basic estimates the size of druggable human genome. J Mol Model 2009;15: 695-9.
49. Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. IntJ Pharm 2008;363:1-25.
50. Okuda H, Ogura K, Kato A, et al. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. J Pharmacol ExpTher 1998;287:791-9.
51. Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010;330:831-5.
52. Kaddurah-Daouk R, Baillie RA, Zhu H, et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. PLoS One 2011;6:e25482.
53. Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 2011;12:103-11.
54. Wilson ID. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. ProcNatlAcad SciUSA 2009;106:14187-8.
55. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009; 136:2015-31.
56. Shanahan F. Probiotics in perspective. Gastroenterology 2010;139:1808-12.
57. Quigley EM. Gut microbiota and the role of probiotics in therapy. Curr Opin Pharmacol 2011;11(6):593-603.
58. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007;335:80.
59. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr 2007;137:2420-4.
60. Bailey JR, Probert CSJ, Cogan TA. Identification and characterisation of an iron-responsive candidate probiotic. PLoS One 2011;6:e26507.
61. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009;15:128-33.
62. Landy J, Al-Hassi HO, McLaughlin SD, et al. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment PharmacolTher 2011;34:409-15.
63. Dethlefsen L, Huse S, Sogin ML, etal. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
64. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011;476:393-4.
65. Proal AD, Albert PJ, Blaney GP, et al. Immunostimulation in the era of the metagenome. Cell Mol Immunol 2011;8: 213-25.
66. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes ObesMetab 2011;14:112-20.
67. Payne DJ, Gwynn MN, Holmes DJ, et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat RevDrug Discov 2007;6:29-40.
68. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
69. Feria-Gervasio D, Denis S, Alric M, et al. In vitro maintenance of a human proximal colon microbiota using the continuous fermentation system P-ECSIM. Appl Microbiol Biotechnol 2011;91:1425-33.
70. Ellrott K, Jaroszewski L, Li W, et al. Expansion of the protein repertoire in newly explored environments: human gut microbiome specific protein families. PLoS Comput Biol 2010;6:e1000798.
71. Zaneveld J, Turnbaugh PJ, Lozupone C, et al. Host-bacterial coevolution and the search for new drug targets. Curr Opin Chem Biol 2008;12:109-14.
72. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. NatRev Immunol 2011;11:9-20.
73. Knight P, Campbell BJ, Rhodes JM. Host-bacteria interaction in inflammatory bowel disease. BrMed Bull 2008;88: 95-113.
74. Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe 2011;17:490-5.
75. Peterson J, Garges S, Giovanni M, et al. The NIH Human Microbiome Project. Genome Res 2009;19:2317-23.
76. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev InfectDis 1988;10:S274-6.
77. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. NatMethods 2010;7:335-6.
78. Meyer F, Paarmann D, D'Souza M, et al. The metagenomics RAST server - a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics 2008;9:386.
79. Hamady M, Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 2009;19:1141-52.
80. O'Sullivan O, O'Callaghan J, Sangrador-Vegas A, et al. Comparative genomics of lactic acid bacteria reveals a niche-specific gene set. BMCMicrobiol 2009;9:50.
81. Lee J-H, Karamychev VN, Kozyavkin SA, et al. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMCGenomics 2008;9:247.
82. Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 2008;4: 447-57.
83. Hugenholtz P, Goebel BM, Pace NR. Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 1998;180:4765-74.
84. Amann RI, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 1995;59:143-69.
85. Wu GD, Lewis JD, Hoffmann C, et al. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol 2010;10:206.
86. Kembel SW, Eisen JA, Pollard KS, et al. The phylogenetic diversity of metagenomes. PLoS One 2011;6:e23214.
87. Sharpton TJ, Riesenfeld SJ, Kembel SW, etal. PhylOTU: a high-throughput procedure quantifies microbial community diversity and resolves novel taxa from metagenomic data. PLoSComput Biol 2011;7:e1001061.
88. Huson DH, Auch AF, Qi J, et al. MEGAN analysis of metagenomic data. Genome Res 2007;17:377-86.
89. Costello EK, Gordon JI, Secor SM, et al. Postprandial remodeling of the gut microbiota in Burmese pythons. ISMEJ 2010;4:1375-85.
90. Caporaso JG, Lauber CL, Costello EK, et al. Moving pictures of the human microbiome. GenomeBiol 2011;12:R50.
91. Lozupone C, Hamady M, Knight R. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006;7:371.
92. Moore JH, Lari RCS, Hill D, et al. Human microbiome visualization using 3d technology. Pac Symp Biocomput 2011;154-164.
93. Ondov BD, Bergman NH, Phillippy AM. Interactive metagenomic visualization in a Web browser. BMC Bioinformatics 2011;12:385.
94. Fierer N, Lauber CL, Zhou N, et al. Forensic identification using skin bacterial communities. Proc Natl Acad Sci USA 2010;107:6477-81.
95. White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoSComput Biol 2009;5:e1000352.
96. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
97. Medini D, Donati C, Tettelin H, et al. The microbial pan-genome. Curr Opin Genet Dev 2005;15:589-94.
98. Frese SA, Benson AK, Tannock GW, et al. The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri. PLoS Genet 2011;7:e1001314.
99. Xu J, Mahowald MA, Ley RE, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007;5: e156.
100. Steck N, Mueller K, Schemann M, et al. Bacterial proteases in IBD and IBS. Gut. doi:10.1136/gutjnl-2011-300775.
101. Liu B, Pop M. MetaPath: identifying differentially abundant metabolic pathways in metagenomic datasets. BMC Proc 2011;5(Suppl 2):S9.
102. Larsen PE, Collart FR, Field D, et al. Predicted Relative Metabolomic Turnover (PRMT): determining metabolic turnover from a coastal marine metagenomic dataset. Microb Inform Exp 2011;1:4.
103. Kurokawa K, Itoh T, Kuwahara T, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007;14:169-81.
104. Ellrott K, Jaroszewski L, Li W, et al. Expansion of the protein repertoire in newly explored environments: human gut microbiome specific protein families. PLoS Comput Biol 2010;6:e1000798.
105. Valencia A. Automatic annotation of protein function. Curr Opin Struct Biol 2005;15:267-74.
106. Hildebrand A, Remmert M, Biegert A, et al. Fast and accurate automatic structure prediction with HHpred. Proteins 2009;77(Suppl 9):128-32.
107. Kalev I, Habeck M. HHfrag: HMM-based fragment detection using HHpred. Bioinformatics 2011;27:3110-6.
108. Godzik A. Metagenomics and the protein universe. Curr Opin Struct Biol 2011;21:398-403.
109. Kurokawa K, Itoh T, Kuwahara T, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007;14:169-81.
110. Lingner T, Asshauer KP, Schreiber F, et al. CoMet-a web server for comparative functional profiling of metagenomes. Nucleic Acids Res 2011;39:W518-23.
111. Sun Y, Anil Wipat, Pocock M, et al. A grid-based system for microbial genome comparison and analysis. IEEE International Symposium on CCGRID 2005;2:977-84.
112. Matsunaga A, Tsugawa M, Fortes J. CloudBLAST: Combining MapReduce and Virtualization on distributed resources for bioinformatics applications. IEEE International Conference on eScience 2008;0:222-9.
113. Kellermayer R, Dowd SE, Harris RA, et al. Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J 2011;25:1449-60.
114. Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell 2008;134:714-7.
115. Cockell SJ, Weile J, Lord P, et al. An integrated dataset for in silico drug discovery. J Integr Bioinform 2010;7.
116. Gao H, Dahlman-Wright K. From DNA binding to metabolic control: integration of -omics data reveals drug targets for prostate cancer. EMBOJ 2011;30:2516-7.
117. Abubucker S, Segata N, Goll J, et al. HUMAnN:TheHMP Unified Metabolic Analysis Network j The Huttenhower Lab. http://www.huttenhower.org/humann (12 December 2011, date last accessed).
118. IMG Home. http://img.jgi.doe.gov/cgi-bin/w/main.cgi (15 December 2011, date last accessed).
119. Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011;27:431-2.
120. Weile J, Pocock M, Cockell SJ, et al. Customizable views on semantically integrated networks for systems biology. Bioinformatics 2011;27:1299-306.
121. Lee I, Date SV, Adai AT, et al. A probabilistic functional network of yeast genes. Science 2004;306:1555-8.
122. Yang JY, Karr JR, Watrous JD, et al. Integrating "-omics"and natural product discovery platforms to investigate metabolic exchange in microbiomes. Curr Opin Chem Biol 2011;15:79-87.
123. Barnes MR, Harland L, Foord SM, et al. Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery. Nat RevDrug Discov 2009;8:701-8.
124. ®. http://www.gopubmed.org/web/gopub med/1?WEB10O00h00100090000 (12 December 2011, date last accessed).
125. Crawford PA, Crowley JR, Sambandam N, et al. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad SciUSA 2009;106:11276-81.
126. Garrett WS, Gallini CA, Yatsunenko T, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. CellHostMicrobe 2010;8:292-300.